Role of human cytomegalovirus (HCMV)-specific antibody in HCMV-infected pregnant women

Early Human Development

Volumn 90, Issue SUPPL.1, 2014, Pages

  Revello, Maria Grazia ^a   Fornara, Chiara ^a   Arossa, Alessia ^a   Zelini, Paola ^a   Lilleri, Daniele ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Congenital infection; Human cytomegalovirus; Maternal antibodies

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; HYPERIMMUNE GLOBULIN; MATERNAL ANTIBODY; PLACEBO; MEMBRANE PROTEIN; NEUTRALIZING ANTIBODY; UL128 PROTEIN, HUMAN CYTOMEGALOVIRUS; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CYTOMEGALOVIRUS; INFECTION PREVENTION; PASSIVE IMMUNIZATION; PREGNANT WOMAN; REVIEW; VERTICAL TRANSMISSION; CLINICAL TRIAL (TOPIC); CYTOMEGALOVIRUS INFECTIONS; FEMALE; IMMUNOLOGY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREVENTION AND CONTROL;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CLINICAL TRIALS AS TOPIC; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MEMBRANE GLYCOPROTEINS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL ENVELOPE PROTEINS;

EID: 84897491194     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/S0378-3782(14)70011-8     Document Type: Review

References (15)

1. Alford CA, Britt WJ Cytomegalovirus. Virology 1990, 1981-2010. Raven Press, Ltd., New York. 2nd editiom. B.N. Fields, D.M. Knipe (Eds.).
2. Revello MG, Fabbri E, Furione M, Zavattoni M, Lilleri D, Tassis B, et al. Role of prenatal diagnosis and counselling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection. A 20-year experience. J Clin Virol 2011, 50:303-307.
3. Dollard SC, Grosse SD, Ross DS New estimates of the prevalence of neurological sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007, 17:355-363.
4. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992, 326:663-667.
5. Lilleri D, Fornara C, Furione M, Zavattoni M, Revello MG, Gerna G Development of cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus. J Infect Dis 2007, 195:1062-1070.
6. Hahn G, Revello MG, Patrone M, Percivalle E, Campanini G, Sarasini A, et al. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 2004, 78:10023-10033. Erratum in: J Virol 2009;83:6323.
7. Gerna G, Percivalle E, Baldanti F, Revello MG Lack of transmission to polymorphonuclear leukocytes and human umbilical vein endothelial cells as a marker of attenuation of human cytomegalovirus. J Med Virol 2002, 66:333-339.
8. Wang D, Shenk T Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci USA 2005, 102:18153-18158.
9. Ryckman BJ, Rainish BL, Chase MC, Borton JA, Nelson JA, Jarvis MA, et al. Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J Virol 2008, 82:60-70.
10. Kinzler ER, Theiler RN, Compton T Expression and reconstitution of the gH/gL/gO complex of human cytomegalovirus. J Clin Virol 2002, 25:S87-S95.
11. Gerna G, Sarasini A, Patrone M, Percivalle E, Fiorina L, Campanini G, et al. Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. J Gen Virol 2008, 89:853-865.
12. Macagno A, Bernasconi N, Vanzetta F, Dander E, Sarasini A, Revello MG, et al. Isolation of human monoclonal antibodies that potently neutralize HCMV infection by targeting different epitopes on the gH/gL/UL128-131A complex. J Virol 2010, 84:1005-1013.
13. Revello MG, Gerna G Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications. Rev Med Virol 2010, 20(3):136-155. 10.1002/rmv.645.
14. Lilleri D, Kabanova A, Revello MG, Percivalle E, Sarasini A, Genini E, et al. Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection. PLos One 2013, 8(3):e59863. 10.1371/journal.pone.0059863.
15. Nigro G, Adler SP, La Torre R, Best AM Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005, 353:1350-1376.